Skip to main content

Table 1 Clinical parameters of the TCGA and GEO cohort

From: Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer

Characteristics

TCGA cohort (N = 1076)

GEO cohort (N = 327)

Age (years)

  ≤ 65

773 (71.84)

305 (93.27)

  > 65

303 (28.16)

22 (6.73)

Gender

  

 Female

1064 (98.88)

327 (100)

 Male

12 (1.12)

 

T classification

 T1

281 (26.12)

101 (30.89)

 T2

621 (57.71)

188 (57.49)

 T3

133 (12.36)

26 (7.95)

 T4

38 (3.53)

12 (3.67)

 NA

3 (0.28)

 

N classification

 N0

504 (46.84)

137 (41.90)

 N1

361 (33.55)

87 (26.61)

 N2

120 (11.15)

63 (19.27)

 N3

74 (6.88)

40 (12.22)

 NA

17 (1.58)

 

M classification

 M0

895 (83.18)

319 (97.55)

 M1

22 (2.04)

8 (2.45)

 NA

159 (14.78)

 

Stage

  

 St1

183 (17.01)

 

 St2

608 (56.51)

 

 St3

242 (22.49)

 

 St4

24 (2.23)

 

 NA

23 (1.76)